Skip to content
Search

Latest Stories

Dementia diagnoses in England reach record high, NHS figures reveals

Dementia diagnoses in England reach record high, NHS figures reveals
NHS dementia diagnosis statistics
England’s top dementia doctor emphasises that getting a diagnosis is the first step in supporting people living with the illness  

The latest NHS data showed that 487,432 individuals in England were diagnosed with dementia in June, the highest since the start of the pandemic.

Although dementia diagnosis rates have reached 65 per cent, the NHS still aims to meet its target of diagnosing 66.7 per cent of the estimated total number of people living with a form of the disease.


NHS stated that their staff across the country are actively assessing care home residents to identify more individuals who may have dementia.

Dr. Jeremy Isaacs, National Clinical Director for Dementia at NHS England, praised the efforts of NHS staff in increasing diagnosis rates but acknowledged that more work is needed.

“Getting a diagnosis of dementia is the first step in supporting people, with a wide range of NHS services able to help.

“NHS staff have worked hard to recover services with the number of people with a diagnosis rising significantly over the last year, and now at a record level, but there is more work to be done.

“Thousands more individuals are being diagnosed each month and more medication reviews are being done within 12 months,” he said.

According to the health service, England has one of the highest dementia diagnosis rates in the world, with high-income countries typically ranging between 20-50 per cent.

The NHS noted that a timely diagnosis is crucial for ensuring that people receive the necessary support and care to manage the illness.

It is encouraging people to come forward and get checked if they exhibit any common early signs or symptoms of dementia.

According to Dr. Isaacs, common early symptoms of dementia include:

  • Forgetting bits of information
  • Saying the same thing repeatedly
  • Struggling to follow a conversation or find the right word
  • Being confused about time and place

He added that these problems are often more noticeable to the person’s family and friends than to the individual themselves.

Emphasising the importance of early detection, he said: "If you have noticed that someone has symptoms, please encourage them to visit their GP for an assessment – the sooner someone is seen, the quicker the NHS can help."

NHS figures also showed that 86,434 people with a dementia diagnosis had their medication reviewed in the preceding 12 months, up from 77,112 in June 2023.

In 2022, NHS England announced 14 new pilot schemes in which specialist nurses and other healthcare professionals proactively assess care home residents for dementia.

These initiatives are part of the ongoing efforts to improve dementia care and diagnosis rates across the country.

A study by Future Health has predicted that the number of dementia cases in the UK could rise to 1.5 million by 2040.

The study also cautioned that over half a million people with dementia could remain undiagnosed by 2040, representing an increase of nearly a quarter of a million compared to the current figure, if there is “no progress in improving diagnosis rates.”

Currently, approximately 850,000 individuals in the UK are estimated to be living with dementia, with an estimated 315,000 cases going undiagnosed.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less